title: [Advanced nonsmall cell lung cancer: importance of chemotherapy in the control of symptoms].
abstract: Chemotherapy in advanced non-small-cell lung cancer may be a controversy because it is only palliative and costly. Benefit of chemotherapy is nevertheless clear in survival and particularly life quality. Beside this technical criteria, two other factors have an impact on the therapeutic decision: symptom control and patient's personal expectations. The aim of the strategy is to determine an acceptable compromise in each situation.
authors.forename: Jacques
authors.initials: J
authors.lastname: Margery
authors.forename: Sylvestre
authors.initials: S
authors.lastname: Le Moulec
authors.forename: Frédéric
authors.initials: F
authors.lastname: Grassin
authors.forename: Olivier
authors.initials: O
authors.lastname: Bauduceau
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Dot
authors.forename: Lionel
authors.initials: L
authors.lastname: Vedrine
authors.forename: François
authors.initials: F
authors.lastname: Natali
authors.forename: Joël
authors.initials: J
authors.lastname: Guigay
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011788:Quality of Life